+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

The effect of study design on the pharmacodynamics of nizatidine



The effect of study design on the pharmacodynamics of nizatidine



Pharmacotherapy 10(3): 236




(PDF emailed within 1 workday: $29.90)

Accession: 033784358

Download citation: RISBibTeXText



Related references

The Effect of Nizatidine, a MATE2K Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Volunteers. Clinical Pharmacokinetics 55(4): 495-506, 2015

The effect of previous administration of nizatidine on the neuromuscular effects of vecuronium and the effect of nizatidine on gastric secretion. Anaesthesia and Intensive Care 28(1): 46-48, 2000

Pharmacokinetics and pharmacodynamics of oral nizatidine. Journal of Clinical Pharmacology 28(1): 71-75, 1988

Developmental pharmacokinetics and pharmacodynamics of nizatidine. Journal of Pediatric Gastroenterology and Nutrition 38(4): 442-451, 2004

Pharmacokinetics and pharmacodynamics of nizatidine in young infants. Clinical Pharmacology & Therapeutics 73(2): P38, February, 2003

Pharmacokinetics and pharmacodynamics of a novel nizatidine controlled-release formulation in healthy subjects. Journal of Clinical Pharmacology 43(1): 74-83, January, 2003

Diurnal variation in pharmacokinetics and pharmacodynamics of nizatidine in healthy volunteers and in patients with duodenal ulcer. Gastroenterology 108(4 SUPPL ): A156, 1995

Nizatidine versus placebo in gastro-oesophageal reflux disease: a 6-week, multicentre, randomised, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group. British Journal of Clinical Practice. Supplement 76: 11-19, 1994

Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer. Nizatidine Multicenter Duodenal Ulcer Study Group. American Journal of Gastroenterology 84(7): 769-774, 1989

Nizatidine in peptic ulcer disease. Proceeedings of the First International Symposium on Nizatidine. Vienna, 11 and 12 October 1986. Scandinavian Journal of Gastroenterology. Supplement 136: 1-88, 1987

Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg. Journal of Clinical Pharmacology 33(1): 70-74, 1993

Continuous infusions of nizatidine are safe and effective in the treatment of intensive care unit patients at risk for stress gastritis. The Nizatidine Intensive Care Unit Study Group. Scandinavian Journal of Gastroenterology. Supplement 206: 29-34, 1994

Nizatidine versus placebo in gastroesophageal reflux disease. A six-week, multicenter, randomized, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group. Digestive Diseases and Sciences 37(6): 865-874, 1992

Effect of nizatidine on olanzapine-associated weight gain in schizophrenic patients in Korea: a pilot study. Human Psychopharmacology 18(6): 453-456, 2003

Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h. Gut 29(10): 1364-1369, 1988